StockpollyBeta
Get App
Popularity #1,954
WVE · NASDAQ · Biotechnology

Wave Life Sciences (WVE)

Develops PRISM-based RNA medicines across editing, silencing, splicing, and RNAi.

$4.35
After hours+0.00 (+0.00%)
At close$4.35(+2.23%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue49291320−88499817382
Cost of revenue3220000220200
Gross profit18271320−88477815382
134647555661575964717076
Research & development323433404145414346534751
131414141516181818212225
General & administrative131414141516181818212225
Other expenses−32−20000−2−20−200
Operating income4−19−34−35−6423−50−53−56−56−31−74
323226323354
Interest income223224322355
Other non-operating income0−2−3−2−2−6−3−2−3−3−50
Income before tax8−16−32−33−6229−47−50−54−53−26−69
Income tax expense100000000000
Net income from continuing operations7−16−32−33−6229−47−50−54−53−26−69
Net income7−16−32−33−6229−47−50−54−53−26−69
EPS, basic$0.07−$0.15−$0.24−$0.25−$0.47$0.18−$0.29−$0.31−$0.32−$0.30−$0.13−$0.34
EPS, diluted$0.07−$0.15−$0.24−$0.25−$0.47$0.17−$0.29−$0.31−$0.32−$0.30−$0.13−$0.34
Weighted average shares, basic106110129130131161163164168180200202
Weighted average shares, diluted107110129130133172163164168180200202
EBITDA6−14−29−31−6031−45−48−52−51−24−71
Depreciation & amortization122222222222
EBIT4−16−32−33−6229−47−50−54−53−26−74